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Abstract
Introduction Sepsis and severe sepsis are asociated with high hospital mortality. Little is known about
the occurrence of sepsis in general hospital populations. The goal of the present study was to reveal
the epidemiology of sepsis in Norwegian hospitals over 1 year.
Methods Patients admitted to all Norwegian hospitals during 1999 (n = 700,107) were analyzed by
searching the database of the Norwegian Patient Registry for markers of sepsis, using International
Classification of Diseases (ICD)-10 codes for sepsis and severe infections. In patients with such
diagnoses, demographic data, hospital outcome data and ICD-10 codes for organ dysfunction were
also retrieved. Sepsis was further classified as primary or secondary, and severe (sepsis with vital organ
dysfunction) or nonsevere. The age-adjusted mortality rate, and the sepsis rates for all hospital
admissions and in the Norwegian population were calculated.
Results A total of 6665 patients were classified as having sepsis, and of these 2121 (31.8%) had
severe sepsis. The most frequent failing organ system was the circulatory system, and 1562 had septic
shock. Mortality increased from 7.1% (in those with no documented organ dysfunction) to 71.8% (in
those with three or more organ dysfunctions). The mean mortality was 13.5%, and the mortality of
severe sepsis was 27%. The incidence of sepsis was 9.5/1000 hospital admissions and 1.49/1000
inhabitants in 1999.
Conclusion Sepsis is not uncommon in Norwegian hospitals and is associated with high hospital
mortality, which is similar to recent findings from the USA. Awareness of sepsis and its appropriate
treatment is mandatory in Norway if we are to reduce mortality from sepsis by 25% in the next 5 years.
Keywords: epidemiology, mortality, Norway, sepsis, severe sepsis
Introduction
Sepsis is an increasing problem in modern medicine. Some
explanations for this are an increasing proportion of elderly
people in the general population and those admitted to hospi-
tals, more intensive and aggressive treatment of various dis-
eases and injuries, and increased microbial resistance,
especially in the hospital environment. Recent reports from the
USA suggest that sepsis is a serious national health problem,
on the same level as ischaemic heart disease, and that the
number of deaths due to severe sepsis is similar to the number
of deaths related to ischaemic heart disease [1]. Published
estimates of the prevalence of sepsis in European countries
are scarce; the present study was conducted to gain national
data on the incidence and mortality from sepsis and severe
sepsis in Norway.
Methods
The present study used data from the Norwegian Patient Reg-
istry (NPR) at Sintef Unimed in Trondheim, Norway. The NPR
is a national database in which all Norwegian hospitals must
register information on all admissions each year. For each hos-
pital stay, anonymous patient data (age, sex and year of birth),
dates for hospital admission and discharge, type of hospital
and department, vital status at discharge, International Classi-
fication of Diseases (ICD)-10 diagnostic codes [3] (grouped
as primary diagnosis and secondary diagnosis) and codes for
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operative procedures (NOMESCO Classification of Surgical
Procedures coding) [4] are registered. The database is not
open for general access, but it is possible to request specific
searches of the database. The year 1999 was chosen
because this was the most recent year at the start of the study
(2002) for which complete data were available. All patients
(except neonates) with a diagnosis (primary or secondary) of
sepsis or severe infection (Table 1) admitted to all Norwegian
hospitals were identified. We deliberately excluded codes for
neonatal sepsis because this was not the focus of the study.
In addition, secondary codes (up to four) were retrieved for all
patients identified by the primary search. In this search we also
requested data regarding hospital stay (days), type of depart-
ment, vital status at discharge (dead or alive), and age and sex
of the patient. Because intensive care units (ICUs) in Norway
are not independent administrative units in the hospital, but
have 'technical' beds, the patients continue to be registered as
admitted to the original department. Hence, it was not possi-
ble to extract data from the registry about stay in the ICU for
this cohort of patients.
The extracted patient data were transferred to a local database
(FileMaker, Inc, Pro 6.0, Santa Clara, USA and SPSS Inc, ver-
sion 11, Chicago, USA), and in that database we conducted a
search for patients with secondary diagnostic codes indicat-
ing acute organ dysfunction (Table 2). This was performed in
order to identify a subgroup of patients with severe sepsis,
defined as sepsis with one or more organ dysfunction. The
total patient group was then divided into patients with sepsis
and severe infection as a primary admission code and those
with sepsis and severe infection as a secondary code (origi-
nated at the hospital), and into sepsis with and without evi-
dence of acute organ dysfunction. We also analyzed the
patient group with regard to incidence and mortality in the Nor-
wegian population (given as events/1000 inhabitants) and in
different age groups (10-year cohorts). The number of inhabit-
ants in Norway was 4,461,913 (population average in 1999)
and the number of people in the different age cohorts that year
was used to calculate age-specific incidence of sepsis [5].
The total number of hospital admissions in Norway was,
according to the NPR, 700,107 in 1999 [6].
Results
In the primary search group 6665 patients were identified,
3441 of whom were male and 3224 were female. The mean
age was 57.9 years. This yields a sepsis incidence of 1.49
cases/1000 inhabitants in the year 1999. In total, 3517
patients (52.8%) had this as their main diagnosis, and 2121
patients (31.8%) had severe sepsis (sepsis with at least one
ICD-10 code indicating acute organ dysfunction). In the latter
group septic shock was the largest subgroup, including 1562
patients. Mean age and mortality in different subgroups are
shown in Table 3, in which patients with septic shock are also
listed. The risk for death from sepsis increases with the
number of organs with dysfunction (Fig. 1).
The incidence of sepsis was low in those aged under 1 year
(1.1/1000) and stayed low up to approximately 50 years of
age (<1/1000). From this age the incidence of sepsis
increased to 8.7/1000 in those older than 80 years. Mortality
from sepsis increased with age, to a maximum of 28% in those
older than 80 years (Fig. 2). Bacterial identification in patients
with sepsis was coded in 2020 cases (30.3%), and the distri-
bution is shown in Fig. 3.
Resource consumption in patients with sepsis is considerable,
as illustrated by the mean hospital stay of 14.9 days, and the
total number of days spent in hospital was 97,178. The sepsis
rate calculated from the number of hospital admissions was
9.5/1000 admissions, and severe sepsis occurred in 3.0/
1000 admissions.
Discussion
In this analysis of the incidence of sepsis in Norwegian hospi-
tals in 1999, a frequency of 1.49 sepsis cases/1000 inhabit-
ants was found, with an overall mortality of 13.5%. Severe
sepsis was found in 31.8% of the patients, with a hospital mor-
tality of 27%.
These figures clearly show that sepsis in Norway is common
and carries a poor prognosis, with 897 deaths in 1999. How-
ever, this is still far from the number of deaths that follow acute
myocardial infarction (5599 persons in 1999), which is con-
trary to the situation in USA [1].
It must be underlined that data taken from such a registry are
associated with a certain degree of uncertainty. Data are not
prospectively collected with the use of strict definitions of sep-
sis and severe sepsis. Sepsis is a syndrome (systemic inflam-
matory response) caused by an infection [7], and it is not
considered as a single diagnosis or diagnostic group in the
ICD-10 coding system. The definition has been challenged
recently, and other methods to define and describe sepsis
have been suggested [8]. The extent to which Norwegian phy-
Table 1
ICD-10 codes including in this search (primary and secondary 
diagnosis)
Code Diagnosis
A26.7 Erysipelas
A39 Meningococcal infections
A40.0 Streptococcal sepsis
A41.0–A41.9 Other bacterial sepsis
A42.7 Actinomycosis sepsis
B37.7 Candida sepsis
T81.4 Infections after surgical procedures
ICD, International Classification of Diseases.Available online http://ccforum.com/content/8/4/R180
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sicians use the same definition of sepsis is therefore very
difficult to estimate. Because data are registered anonymously
in the NPR, it is not possible to perform a quality check on the
data in retrospect. Such shortcomings are present in most
similar registries.
In Norway there has been a tendency to equate sepsis to a
positive blood culture (i.e. growth of bacteria or fungi in blood).
This is clearly not the case, as was once again demonstrated
in the most recent, large clinical trial in patients with sepsis, in
which the use of recombinant human activated protein C in
severe sepsis was evaluated [9]. In that study only one-third of
all included patients had a positive blood culture. Moreover,
growth of bacteria in the blood (bacteraemia) does not mean
that the patient will necessarily develop sepsis.
Severe sepsis is not found in the ICD-10 coding system. In
order to code for severe sepsis, a code for sepsis (or severe
infection) with one or more codes for organ dysfunction must
be applied. Coding organ dysfunction is a problem in itself
because organ dysfunction is poorly defined, and no interna-
tionally accepted definitions exist, even for the most common
organ dysfunctions. Short episodes (lasting less than 24
hours) of organ dysfunction, such as respiratory failure with
hypoxaemia or circulatory failure with hypotension, can be
overlooked. Only when the organ dysfunction is severe
enough to initiate specific treatment (such as the use of
vasoactive drugs, ventilator treatment, and renal replacement
therapy) is there a greater chance that it will be included in the
diagnostic records at discharge.
Table 2
ICD-10 codes included in the search for organ dysfunction (only secondary codes)
Organ dysfunction Code Diagnosis
Circulatory failure A41.9 Septic shock
I50.9 Unspecified heart failure
Respiratory failure J13-18 Pneumonias
J80 ARDS
J95 Respiratory failure after procedures
J96.0 Acute respiratory failure
Renal failure N17 Acute renal failure
N99.0 Acute renal failure after treatment
Coagulation failure D65 DIC
D69 Purpura and other bleeding instances
Other organ dysfunctions E86 Fluid loss
E87.2 Metabolic acidosis
K72 Acute liver failure
ARDS, acute respiratory distress syndrome; DIC, disseminated intravascular coagulation; ICD, International Classification of Diseases.
Table 3
Mean age and mortality in different subgroups of patients with sepsis
Group n Mean age (years) Mean length of stay (days) Mortality (n [%])
All 6665 57.9 14.9 897 (13.5%)
Primary sepsis 3517 57.9 10.4 508 (14.4%)
Secondary sepsis 3148 56.9 20.3 389 (12.4%)
Sepsis without organ failure 4544 57.1 14.3 323 (7.1%)
Severe sepsis 2121 57.9 16.1 574 (27%)
Septic shock 1562 54.2 14.3 457 (29.3%)Critical Care    August 2004  Vol 8 No 4    Flaatten 
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Another uncertainty is the inclusion of severe infections in our
search as substitutes for diagnosis of sepsis. Some of these
patients might have had only localized infections, with little or
no systemic inflammation. However, most probably fulfil at
least three of the four sepsis criteria, and hence were included
in the search.
In Haukeland University Hospital the number of patients with
growth in blood culture increased from 4.3/1000 admissions
in the period 1974–1979 to 8.7/1000 admissions in 1988–
1989 [10]. In the present study, conducted 10 years later, we
found the incidence of sepsis to be 9.5/1000 admissions.
In general, few studies have been published on the national
incidence of sepsis in different countries. In a literature search,
only two such studies, both from the USA, were found [1,2].
Several studies have been published regarding the occur-
rence of sepsis in patients confined to the ICU [11-13] or in
different hospitals [10,14], or the occurrence of specific forms
of sepsis, such as meningococcal sepsis [15,16]. Such stud-
ies, however, are not easy to compare with the present one. In
a recent large prospective study conducted in Australia and
New Zealand [13] the calculated annual incidence of severe
sepsis was found to be 0.77/1000 population per year, which
is similar to the 0.8/1000 population per year found in the
study reported by Martin and coworkers [2] using retrospec-
tive data from the National Centre for Health Statistics (similar
to the NPR). In the latter study the occurrence of all sepsis was
found to be 2.5 cases/1000 inhabitants per year. These fig-
ures are higher but similar to our finding of 1.5 and 0.5 cases
of sepsis and severe sepsis/1000 inhabitants per year.
Both sepsis and severe sepsis carry high hospital mortality. In
the study by Angus and coworkers [1] the mortality of severe
sepsis was 28.6%, which is very similar to the 27% that we
found in patients with severe sepsis. In the study by Martin and
coworkers [2], increased mortality with increasing numbers of
organs in failure was demonstrated. They found the mortality
for sepsis without organ failure to be 15%, increasing to 70%
with three or more organ failures [2]; this is nearly identical to
our findings.
Conclusion
Sepsis and severe sepsis are not uncommon in Norwegian
hospitals and carry a severe prognosis. In severe sepsis the
mortality was 27% and was found to increase with the number
of organs in failure. Sepsis must be given greater priority in
general health discussions and education of health personnel
in our country. An international campaign to reduce the mortal-
ity from sepsis by 25% in the coming 5 years is presently
ongoing [17]; it will be of interest to see whether we can
achieve this goal in Norway.
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Key messages
The incidences of sepsis and severe sepsis have 
increased over the past few decades. Sepsis carries a 
poor prognosis, with mortality increasing with the 
number of organs in failure.
The overall sepsis rate in Norway 1999 was 1.49/1000 
inhabitants.
The rate of severe sepsis was 0.5/1000 inhabitants.